AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$2.50
+0.03 (+1.21%)
Open$2.50
Previous Close$2.47
Day High$2.54
Day Low$2.49
52W High$3.07
52W Low$1.20
Volume—
Avg Volume34.4K
Market Cap26.83M
P/E Ratio—
EPS$-3.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+266.0% upside
Current
$2.50
$2.50
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 113.46M | 128.62M | 4.25M |
| Net Income | -23,179,435 | -23,649,803 | 1.24M |
| Profit Margin | -20.4% | -19.4% | 29.2% |
| EBITDA | -7,082,843 | -7,628,047 | 1.93M |
| Free Cash Flow | — | — | 869.5K |
| Rev Growth | -11.8% | -11.8% | +20.1% |
| Debt/Equity | 1.15 | 1.15 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |